Privi Speciality Chemicals Limited

As of March 31, 2026, Privi Speciality Chemicals Limited carries a market capitalization of 113.20B, placing it among publicly traded companies globally. Its enterprise value stands at 122.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Privi Speciality Chemicals Limited's next confirmed earnings release is scheduled for October 29, 2026.

As of March 31, 2026, Privi Speciality Chemicals Limited has 39.06M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Privi Speciality Chemicals Limited maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026. Inventory turnover of 1.85 indicates how many times Privi Speciality Chemicals Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Privi Speciality Chemicals Limited recorded 881.23M in income tax expense.

As of the close on October 22, 2026, Privi Speciality Chemicals Limited's stock has gained approximately 15.69% over the past 52 weeks. The 50-day moving average sits at 3,461.74, while the 200-day moving average is 3,234.24.

These figures cover the twelve months ended March 31, 2026.

As of March 31, 2026, Privi Speciality Chemicals Limited holds 976.84M in cash and equivalents against 10.21B in total debt, resulting in a net debt position of 9.66B. Total book value stands at 14.12B, with working capital of 5.03B providing operational flexibility.

Privi Speciality Chemicals Limited's most recent stock split took place on July 9, 2014 with a 10:11 split ratio.